Médecine

Paramédical

Autres domaines


S'abonner

Socioeconomic status of patients hospitalized for COVID-19 in the Greater Paris area - 09/06/21

Doi : 10.1016/j.rmr.2021.02.039 
L. Sesé 1, , Y. Nguyen medical 2, E. Giroux Leprieur 3, I. Annesi-Maesano 4, C. Cavalin 5, J. Goupil de Bouillé 6, L. Demestier 7, R. Dhote 8, Y. Tandjaoui-Lambiotte 9, A. Bauvois 10, L. Teillet 11, S. Curac 12, S. Beaune 13, B. Duchemann 14, H. Nunes 15
1 Department of Physiologie and Pulmonology, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University of Paris Nord, Bobigny, France 
2 Department of Internal Medicine, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris, Clichy, France 
3 Department of Pulmonology and thoracic oncology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris, France & Paris-Saclay University UVSQ, EA 4340 BECCOH, Boulogne, France 
4 Epidemiology of Allergic and Respiratory Diseases Department, Institute Pierre Louis of Epidemiology and Public Health, INSERM, and UPMC Sorbonne Université, Medical School Saint Antoine, Paris, France 
5 Social Science Research Institute (IRISSO, UMR CNRS-INRA 7170-1427), Paris-Dauphine University, PSL 
6 Department of Infectious Diseases, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University of Paris Nord, Bobigny, France 
7 Departement of Gastroenterology and Pancreatology, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris, Clichy, France 
8 Department of Internal Medicine, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University of Paris Nord, Bobigny, France 
9 Department of Reanimation, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University of Paris Nord, Bobigny, France 
10 Department of Infectious Diseases, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris, France & Paris-Saclay University UVSQ, EA 4340 BECCOH, Boulogne, France 
11 Department of Geriatrics, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris, France & Paris-Saclay University UVSQ, EA 4340 BECCOH, Boulogne, France 
12 Emergency Departement, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris, Clichy, France 
13 Emergency Departement, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris, France & Paris-Saclay University UVSQ, EA 4340 BECCOH, Boulogne, France 
14 Department of oncology, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University of Paris Nord, Bobigny, France 
15 Department of Pulmonology, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University of Paris Nord, INSERM1272, Bobigny, France 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Background

The potential role of socio-economic status (SES) in COVID-19 remains unknown. The highest excess mortality rate in France linked to COVID-19 is reported in the Seine-Saint-Denis (SSD) district, which is the poorest district of the Greater Paris Area. Our objective was to compare patient characteristics between two districts of Greater Paris and determine whether precarity is a risk factor for severe COVID-19 respiratory disease at hospital admission. We selected patients hospitalized for COVID-19 from three academic hospitals, one located in SSD, and two in the Hauts-de-Seine (HDS) district, a rich district of Greater Paris. All selected patients were prospectively screened on the same day (April 20, 2020). Patients were asked about their SES via a questionnaire and information on smoking habits, comorbidities, and respiratory severity at admission was collected.

Results

112 patients were included (58.6% (65/112) men, age: 66.7±16.3 years old, 11.0% (12/109) Africans or Afro-Caribbeans, and 7.7% (8/104) current smokers). COVID-19 was severe in most cases 59.8% (67/112). The distribution of initial severity was similar in both districts, although SSD patients were approximately 10 years younger than HDS patients (61.8±14.0 versus 71.0±17.1 years old, P=0.002). The proportion of comorbidities was higher in SSD patients, including overweight (29.6±6.08 versus 25.2±5.67, P<0.001) and diabetes (40.0% (20/110) versus 21.7% (13/110) P=0.041), than in HDS patients. SSD patients had lower incomes (monthly income under 800€, 37.8% (17/97) versus 19.6% (9/97), P=0.004), less private insurance coverage (55.8% (29/110) versus 75.9% (44/110) P=0.043), a lower educational level (High school graduate 24.0% (12/103) 56.6% (30/103)versus P=0.002) and a higher housing population density (23.7±22.1 versus 37.3±40.4 m2 per 1 habitant, P=0.027). Although no factor was found to be associated with initial severity in the overall population, age and deprivation index were associated with an increased risk of initial severity in patients under 70 years-old, with an odds ratios of 1.099 (95% CI: 1.038 to 1.178, P=0.003), and 1.029 per deprivation score point (95% CI:1.003 to 1.059, P=0.033), respectively.

Conclusion

Precarity seems to be associated with the initial severity of COVID-19 in hospitalized patients under the age of 70. Low SES and comorbidities may contribute to the excess mortality observed in SSD, the poorest district of Greater Paris with the youngest population.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, Socioeconomic status, Income, Deprivation index


Plan


© 2021  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 38 - N° 6

P. 586-587 - juin 2021 Retour au numéro
Article précédent Article précédent
  • Porphyromonas, a neglected potential key genus of the lung microbiota: description in patients with cystic fibrosis (CF)
  • C.A. Guilloux, C. Lamoureux, S. Gouriou, C. Beauruelle, G. Hery-Arnaud
| Article suivant Article suivant
  • Low income and progression free survival in idiopathic pulmonary fibrosis: An association to uncover
  • L. Sese, J. Caliez, I. Annesi-Maesano, V. Cottin, G. Pesce, M. Didier, Z. Carton, D. Israel-Biet, B. Crestani, S. Guillot Dudoret, J. Cadranel, B. Wallaert, A. Tazi, B. Maître, G. Prévot, S. Marchand-Adam, S. Hirschi, S. Dury, V. Giraud, A. Gondouin, P. Bonniaud, J. Traclet, K. Juvin, R. Borie, J.F. Bernaudin, D. Valeyre, C. Cavalin, H. Nunes

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.